Peritoneal Surface Malignancies
Peritoneal carcinomatosis was once considered an untreatable end-stage disease. Today, with cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC), selected patients can achieve long-term survival and even cure.
Key procedures
- Complete cytoreductive surgery (CRS)
- Hyperthermic intraperitoneal chemotherapy (HIPEC)
- Peritonectomy procedures
- Multivisceral resections
Patient outcomes
15 years of experience in peritoneal carcinomatosis management. The first group for this disease founded in Madrid, at Hospital General Universitario Gregorio Marañón. 50–60 cases per year.
Peritoneal carcinomatosis: survival, HIPEC surgery and who is a candidate →